Novartis CEO Vas Narasimhan says the pharma industry hopes ... Nazis shattered her family’s store in 1938. She just learned it’s still there. I visited the city that's been nicknamed the ...

my family is ready to return to Silicon Valley and the US. I'm confident that Vas will be an excellent successor." Still only 41, Dr. Narasimhan is part of a new generation of leaders taking over ...

I want to thank [CEO Vas Narasimhan] for the opportunity to work at this great company and to everyone in oncology for their commitment to transforming cancer for patients and their families.

Novartis CEO Vas Narasimhan outlined projections for the company's future at the 2025 JP Morgan Healthcare conference in San Francisco on 14 January. Novartis, he said, expects peak sales of over ...

CNBC’s Angelica Peebles and Novartis CEO Vas Narasimhan join 'Squawk Box' to discuss the company's drug pipeline, managing patent cliffs, drug pricing under Trump, and more. TikTok was gone.

Moves by the incoming Trump Administration may be a boon to drugmakers, Novartis AG Chief Executive Officer Vas Narasimhan said, while concerns over vaccine policies and public health funding are ...

As Trump appointee and vaccine skeptic RFK Jr. looks toward Washington, Novartis (NVS) CEO Vas Narasimhan is concerned about the future of healthcare. In a recent episode of Opening Bid ...

even if its main focus remains on therapeutic areas where it currently has an established presence, Chief Executive Vas Narasimhan said in an interview with The Wall Street Journal.

The question is: Will the company take it? “We’re certainly watching the space,” Novartis CEO Vas Narasimhan, M.D., said of PD-1xVEGF bispecifics during a fourth-quarter earnings call with ...

Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...

Novartis said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug.